• Dr. MacKerell to be honored at the ACS Spring 2022 National Meeting, March 20-24, in San Diego March 10, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, announced today its Co-Founder and Chief Scientific Officer, Alexander D. MacKerell Jr., PhD, has been awarded the [...]

    Published On: March 10th, 2022
    Continue Reading
  • Tech on Deck to feature fresh content by Early Charm’s expert team of scientists and entrepreneurs on unmet market needs and challenges March 7, 2022, Baltimore, MD – Early Charm, a company that creates, owns and operates ventures that convert science to revenue, today announced the launch of its Tech on Deck blog. Early Charm’s [...]

    Published On: March 7th, 2022
    Continue Reading
  • Immediate Job Opening – 1/20/2022 Technical Sales Within Early Charm’s Drug Design Portfolio   SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other companies in its Drug Design Portfolio.   What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We are the management [...]

    Published On: January 20th, 2022
    Continue Reading
  • Published On: December 8th, 2021
    Continue Reading
  • FOR IMMEDIATE RELEASE:   SilcsBio Spinout Raises $1.5 Million to Advance Drug Development New investment from Bluedot Bio into Rasio follows initial funding from the National Foundation for Cancer Research   December 2, 2021, Baltimore, MD – Rasio Therapeutics, a joint venture formed by SilcsBio and the National Foundation for Cancer Research (NFCR) to develop [...]

    Published On: December 2nd, 2021
    Continue Reading

Connect with us today to learn more about how we can help your team work faster and more efficiently.


    Browse by Categories